Press Offices

Press Offices

SMC Spain amplifies the voices of experts on current topics that provoke controversy. 

¿Qué me ofrece?

The sources that collaborate with SMC Spain will multiply their national and international media impact. Register your office to become part of a directory on this website that journalists can consult. Our guides on communication and science can help you in your daily work.

Icono
Cómo trabajamos

We will rely on you when we contact sources from your organization or when we organize briefing sessions with them. We will provide you with support resources to facilitate your work. You can learn more about our method here

Título qué me ofrece
What We Offer You
Título cómo trabajamos
How We Work

Ultra-sensitive CAR-T cells offer a potential strategy for treating solid tumors

Although CAR-T cells have been effective against certain blood cancers, they have not worked well in solid tumors due to the lack of a common target on the surface of the cells. A study published today in the journal Science has developed ultra-sensitive CAR-T cells capable of detecting even very low levels of the CD70 protein, a promising target. The researchers succeeded in eradicating kidney, ovarian, and pancreatic tumors in preclinical models.

0

Orforglipron is more effective than semaglutide, according to a phase III clinical trial

The use of the drug orforglipron reduces blood sugar levels and body weight more than semaglutide, the other available oral GLP-1 receptor agonist treatment, according to a phase III clinical trial. The trial, funded by Eli Lilly, involved 1,500 people with type 2 diabetes who took the drug for one year in five countries, and the results are published in The Lancet.

 

 

0

A phase 1 trial is testing a drug to restore the function of p53, the ‘guardian of the genome’, in specific cases

The p53 gene, known as the ‘guardian of the genome’, is a tumor suppressor gene that is mutated in more than half of all solid tumors in humans, affecting the function of the protein it encodes. However, there are no approved treatments capable of reactivating its function. A US team has tested a new drug in a phase 1 clinical trial that is capable of performing this function against a specific mutation, present in approximately 1% of solid tumors. After being administered to 77 people with different types of advanced or metastatic tumors, 20% showed a full or partial response, and the most common adverse effects were nausea or vomiting, according to a report published in NEJM.  

0

A study analyses the relationship between quitting smoking and the risk of developing Parkinson's disease

A study conducted in South Korea collected data from more than 410,000 smokers over an average of nine years. The analyses indicate that the risk of developing Parkinson's disease in those who quit smoking during that period was about 60% higher than in those who continued to smoke; however, their risk of death was lower. According to the researchers, who emphasise that the study does not prove that smoking prevents Parkinson's disease, smoking ‘remains one of the leading causes of preventable death and contributes to the development of heart disease, cancer and chronic lung disease. The health benefits of quitting smoking remain substantial and clear.’ The results are published in Neurology.

0

A single once-daily pill combining two antiretrovirals simplifies HIV treatment, as demonstrated by a phase 3 trial

The combination of the antiretrovirals bictegravir and lenacapavir in a single tablet allows HIV treatment —previously based on multiple daily medications— to be simplified, according to the results of a new phase 3 clinical trial published in The Lancet. The trial, which included over 550 people living with HIV from 15 countries with a median age of 60, showed that the new treatment was just as effective at maintaining viral suppression as multi-drug regimens. Most participants were taking between two and eleven tablets daily, and around 40 % were on antiretrovirals more than once a day. The results were presented at the 2026 Conference on Retroviruses and Opportunistic Infections (CROI) in Denver, USA.

0

A tiny aquatic organism from the Caribbean coast is able to transition between its unicellular and multicellular forms through three different pathways

In the ephemeral pools along the coasts of the Caribbean island of Curaçao lives Choanoeca flexa, a tiny unicellular aquatic organism belonging to the choanoflagellates, important for being close relatives of animals. As the pools evaporate and refill, C. flexa can switch between unicellular and multicellular forms in three different ways: by division, by aggregation, or by combining both, mechanisms that were previously thought to be mutually exclusive. The discovery, published today in Nature, may challenge current understanding of the origins of multicellular life.

0

The Minister of Consumer Affairs announces that the sale of energy drinks to minors under the age of 16 will be banned throughout Spain

Speaking to the media in Barcelona, the Minister for Social Rights, Consumer Affairs and the 2030 Agenda, Pablo Bustinduy, announced that the ministry will ban the sale of energy drinks to minors under the age of 16 in Spain. The regulation will also apply to minors under the age of 18 when the drinks contain more than 32 milligrams of caffeine per 100 millilitres.

0

Marine heatwaves cause an annual decline of almost 20% in fish biomass

New research analysing more than 33,000 fish populations in the northern hemisphere between 1993 and 2021 reveals that chronic ocean warming is driving a long-term decline in biomass of up to 19.8% per year for species in the Mediterranean, North Atlantic and North-East Pacific. At the same time, in the short term, more fish are thriving in cold areas due to the heat, but these increases are temporary and the authors warn that relying on them would lead to unsustainable exploitation. The study, by the National Museum of Natural Sciences (MNCN-CSIC) and the National University of Colombia, is published in Nature Ecology & Evolution.

 

 

0

The Iberian Peninsula and the Canary Islands register the arrival of African air masses with dust concentrations

According to the Ministry for Ecological Transition and Demographic Challenge, masses of African air with varying concentrations of surface dust are expected to reach the Canary Islands and the Iberian Peninsula on Wednesday. Health authorities in different provinces have recommended avoiding outdoor physical exercise or activities that require effort, especially for vulnerable groups such as children, pregnant women, the elderly and the sick.

0

A study shows that carriers of nicotine-related genetic variants smoked fewer cigarettes

Sequencing the genomes of nearly 38,000 smokers in Mexico revealed that variants in a nicotine receptor gene were associated with a lower likelihood of heavy smoking, according to a study published in Nature Communications. The variant occurs in the CHRNB3 gene, which encodes the β3 subunit that binds nicotine and mediates its rewarding effects in the brain. Compared with individuals carrying the more common version of the gene, those with one or two copies of the identified variant smoked 21% and 78% fewer cigarettes, respectively. The findings were validated in populations of Asian and European ancestry.

0